New study seeks best Post-Surgery strategy for advanced oral cancer

NCT ID NCT07457099

Not yet recruiting Disease control Sponsor: Zhujiang Hospital Source: ClinicalTrials.gov ↗

First seen Mar 10, 2026 · Last updated May 10, 2026 · Updated 6 times

Summary

This study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, doctors want to know if radiation therapy, an immunotherapy drug (PD-1 inhibitor), or just watching and waiting works best to keep the cancer from coming back. The study will follow 85 patients for at least a year to compare survival and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ORAL SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Stomatology, Zhujiang Hospital, Southern Medical University, Haizhu District, Guangzhou, Guangzhou, Guangdong 510282

Guangzhou, China

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LOCALLY ADVANCED ORAL SQUAMOUS CELL CARCINOMA LOCALLY ADVANCED ORAL SQUAMOUS CELL CARCINOMA LOCALLY ADVANCED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA